Pemigatinib, an FGFR inhibitor, overcomes resistance to KRASG12C inhibitors in mesenchymal-like NSCLC tumors

被引：0
|
作者：
Favata, Margaret
Weber, Michael
Abdollahi, Angela
Roman, Valerie Dostalik
Farren, Matt
Gilmartin, Aidan
Kim, Sunkyu
Wee, Susan
Rios-Doria, Jonathan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Drug combination screen identifies pemigatinib, an FGFR inhibitor, as a mechanism to overcome KRASG12C inhibitor resistance in lung cancer
    Abdollahi, Angela
    Favata, Margaret
    DiMatteo, Darlise
    Schuette, Sean
    Boarder, Erika
    Rupar, Mark
    Macarron, Ricardo
    Gilmartin, Aidan
    Wang, Hui
    Amador-Arjona, Alejandro
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Resistance looms for KRASG12C inhibitors
    Aaron N. Hata
    Alice T. Shaw
    Nature Medicine, 2020, 26 : 169 - 170
  • [3] Combination of KRASG12C and FGFR1 inhibitors as a resistance-overcoming therapeutic strategy for maximizing therapeutic impact of KRASG12C inhibitors
    Santos, Alba
    Plaza, Patricia
    Jimenez, Marta
    Gomez-Sanchez, David
    Paz-Ares, Luis
    Ferrer, Irene
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Resistance looms for KRASG12C inhibitors
    Hata, Aaron N.
    Shaw, Alice T.
    NATURE MEDICINE, 2020, 26 (02) : 169 - 170
  • [5] Mechanisms of Resistance to KRASG12C Inhibitors
    Dunnett-Kane, Victoria
    Nicola, Pantelis
    Blackhall, Fiona
    Lindsay, Colin
    CANCERS, 2021, 13 (01) : 1 - 14
  • [6] Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
    Negrao, Marcelo V.
    Araujo, Haniel A.
    Lamberti, Giuseppe
    Cooper, Alissa J.
    Akhave, Neal S.
    Zhou, Teng
    Delasos, Lukas
    Hicks, J. Kevin
    Aldea, Mihaela
    Minuti, Gabriele
    Hines, Jacobi
    Aredo, Jacqueline V.
    Dennis, Michael J.
    Chakrabarti, Turja
    Scott, Susan C.
    Bironzo, Paolo
    Scheffler, Matthias
    Christopoulos, Petros
    Stenzinger, Albrecht
    Riess, Jonathan W.
    Kim, So Yeon
    Goldberg, Sarah B.
    Li, Mingjia
    Wang, Qi
    Qing, Yun
    Ni, Ying
    Do, Minh Truong
    Lee, Richard
    Ricciuti, Biagio
    Alessi, Joao Victor
    Wang, Jing
    Resuli, Blerina
    Landi, Lorenza
    Tseng, Shu-Chi
    Nishino, Mizuki
    Digumarthy, Subba R.
    Rinsurongkawong, Waree
    Rinsurongkawong, Vadeerat
    Vaporciyan, Ara A.
    Blumenschein, George R., Jr.
    Zhang, Jianjun
    Owen, Dwight H.
    Blakely, Collin M.
    Mountzios, Giannis
    Shu, Catherine A.
    Bestvina, Christine M.
    Garassino, Marina Chiara
    Marrone, Kristen A.
    Gray, Jhanelle E.
    Patel, Sandip Pravin
    CANCER DISCOVERY, 2023, 13 (07) : 1556 - 1571
  • [7] Vertical inhibition overcomes adaptive resistance to KRASG12C inhibition
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona B.
    Corcoran, Ryan B.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [8] TUSC2 gene therapy in KRASG12C mutant NSCLC overcomes acquired resistance to sotorasib
    Meraz, I.
    Majidi, M.
    Gao, L.
    Ren, C.
    Wu, S.
    Song, R.
    Meng, F.
    Xu, Y.
    Wang, Q.
    Xi, Y.
    Wang, J.
    Jung, S. Y.
    Shpall, E.
    Roth, J. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S145 - S145
  • [9] Sotorasib/SHP2 inhibitors combo, KRASG12C(ON)I and RASMULTI(ON)I effectively target KRASG12C tumors developing secondary resistance to Sotorasib via KRASG12C amplification
    Solanki, Hitendra S.
    Imbody, Denis
    Desai, Bina
    Kato, Ryoji
    Stewart, Paul A.
    Stern, Yaakov
    Majumder, Anurima
    Bridenstine, Liznair
    Sarca, Bhaswati
    Miroshnychenko, Dada
    Aronchik, Ida
    Marusyk, Andriy
    Haura, Eric B.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [10] Understanding the basis for acquired resistance to KRASG12C inhibitors
    Santos Ramos, A.
    Gomez Sanchez, D.
    Rico Lopez, S.
    Plaza Exposito, P.
    Paz-Ares, L.
    Ferrer Sanchez, I.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1411 - S1411
12345